Connection

Otavio Berwanger to Hospitalization

Back to Details
This is a "connection" page, showing publications Otavio Berwanger has written about Hospitalization.
Otavio Berwanger
Connection Strength
0.037
Hospitalization
  1. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 07 29; 385(5):406-415.
    View in: PubMed
    Score: 0.006
  2. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021 06 12; 397(10291):2253-2263.
    View in: PubMed
    Score: 0.006
  3. Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial. Am Heart J. 2021 08; 238:1-11.
    View in: PubMed
    Score: 0.006
  4. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021 01 20; 372:n84.
    View in: PubMed
    Score: 0.006
  5. Hydroxychloroquine with or without Azithromycin in Covid-19. Reply. N Engl J Med. 2021 01 14; 384(2):191.
    View in: PubMed
    Score: 0.006
  6. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 11 19; 383(21):2041-2052.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.